Heterogeneous halothane binding in the SR Ca2+-ATPase  by Kosk-Kosicka, Danuta et al.
FEBS 18132 FEBS Letters 402 (1997) 189-192 
Heterogeneous halothane binding in the SR Ca2+-ATPase 
Danuta Kosk-Kosickaa'*, loulia Fomitchevaa, Maria M. Lopeza, Roderic G. Eckenhofl* 
aJohns Hopkins University, School of Medicine, Dept. of AnesthesiologylCCM, 600 N. Wolfe St., Blalock 1404, Baltimore, MD 21287-4961, USA 
b University of Pennsylvania Medical Center, Dept. of Anesthesia and Physiology, Philadelphia, PA 19104-4283, USA 
Received 17 October 1996; revised version received 13 December 1996 
Abstract The activity of various Ca -ATPases is affected by 
volatile anesthetics, such as halothane, commonly used in clinical 
practice. The effect on the enzyme in skeletal muscle sarcoplas-
mic reticulum (SR) is biphasic, including stimulation at clinical 
anesthetic concentrations and subsequent inhibition at higher 
concentrations. We have previously proposed that the action of a 
volatile anesthetic on Ca -ATPases results from its binding in 
the interior of the enzyme molecule [Lopez, M.M. and Kosk-
Kosicka, D. (1995) J. Biol. Chem. 270, 28239-28245]. Presently, 
we investigated whether the anesthetic interacts directly with the 
skeletal muscle SR Ca2+-ATPase (SERCA1) as evidenced by 
binding. Photoaffinity labeling with |14C]halothane demonstrated 
that the anesthetic binds saturably to SR membranes, and that 
= 80% of the binding is specific, with a Kt of 0.6 mM. The K¡ 
value agrees well with the concentration at which halothane half-
maximally activates SERCA1. SDS gel electrophoresis of 
labeled membranes indicates that 38-56% of |14C]halothane 
incorporates into SERCA1, and 38-53% in lipids. Distribution 
of label among the three fragments produced by controlled 
tryptic digestion of SERCA1 suggests heterogeneous halothane 
binding presumably in discrete sites in the enzyme. The results 
provide the first direct evidence that halothane binds to 
SERCA1. Potentially this binding could be related to anesthetic 
effect on enzyme's function. 
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1. Introduction 
Among several membrane proteins whose functions are af-
fected by volatile anesthetics in vitro are Ca2+-ATPases of 
plasma membranes (PMCA) and intracellular sarcoplasmic/ 
endoplasmic reticulum (SERCA) [1-8]. Previously, we have 
proposed that anesthetics interfere with enzymatic function 
by binding in non-polar sites (cavities) within the protein 
[1]. Our previous studies including fluorescence spectroscopy 
measurements suggest anesthetic binding in the Ca2+-ATPase 
molecule that somehow influences the conformational transi-
tions that the enzyme normally undergoes in its catalytic cycle 
[1]. Whether direct binding to protein is responsible, however, 
needed to be confirmed by a more direct method. Therefore, 
we have used direct photoaffinity labeling with [14C]halothane 
of SERCA 1 of skeletal muscle SR. The technique has previ-
ously been successfully used to examine binding sites in serum 
albumin and a multisubunit membrane protein nAChR [9-
11]. The results obtained through the photochemical approach 
for serum albumin are in very good agreement with other 
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reported studies, using NMR, gas chromatography, and tryp-
tophan fluorescence quenching [12,13]. 
SERCA1 has been extensively studied by numerous labor-
atories. Tryptic fragmentation of SERCA1 has helped to es-
tablish the location of functionally important binding sites, 
including that which binds nucleotide in fragment B (aa 506-
1001) and the phosphorylation site in fragment Ai (aa 199— 
508) [14,16]. The enzyme has been cloned, expressed and ex-
tensively mutated [17-20]. Based on hydrophobicity plots, 
immunological localization of epitopes, chemical derivatiza-
tion, and fluorescence spectroscopy measurements, substantial 
progress has been made in predicting its three-dimensional 
folding of the globular cytosolic part and the transmembrane 
helical segments and the spatial arrangement of functional 
domains (for review, see [19-21]). Thus, the enzyme appears 
to be a reasonable candidate for investigation of anesthetic-
membrane protein interactions. In the present study we find 
that halothane binds to the enzyme molecule, opening the 
possibility of precise identification of the anesthetic binding 
site(s) and potentially the mechanism of interference with the 
normal structural changes involved in the mechanism of long-
range catalytic activation upon Ca2+ binding and phospho-
rylation. 
2. Materials and methods 
[14C]Halothane (2-bromo-2-chloro-1,1,1 -[ 1 -14C]trifluorethane) (spec. 
act. 51.3 mCi/mmol) was obtained from New England Nuclear (Bos-
ton, MA) and diluted with unlabeled halothane to 5 mCi/mmol. Un-
labeled halothane was from Halocarbon Laboratories (Hackensack, 
NJ). Rabbit skeletal muscle SR was prepared in the laboratory of Dr. 
Giuseppe Inesi at the University of Maryland at Baltimore [22]. 
[14C]Halothane photoaffinity labeling of SR was performed at 25°C 
in 0.5 X 4 cm quartz cuvettes in a total volume of 2.0 ml as previously 
described for other proteins [9-11]. Briefly, 4-5 mg SR in buffer con-
taining 10 mM MOPS, pH 7.0 and 30% sucrose, pre-equilibrated with 
100% argon, were incubated either with or without unlabeled (4 mM) 
halothane. Upon addition of [HC]halothane (at 400 uM final concen-
tration) the samples were exposed to 254 nm light (Oriel Pencil cali-
bration lamp at a distance of 5 mm) for 60-100 s with continuous 
stirring. The unbound [14C]halothane was removed by repeated wash-
ing and centrifugation of SR membranes at lOOOOOXg for 30 min. 
The pellet was resuspended in MOPS/sucrose buffer and used for 
trypsin digestion and SDS-polyacrylamide gel electrophoresis (SDS-
PAGE). 
SDS-PAGE was performed according to Laemmli [23] or Weber 
and Osborn [24]. 20-50 ug of protein were loaded per well. Protein 
bands were identified with Coomassie Blue staining. For identification 
and quantitation of the covalently bound [14C]halothane the respec-
tive lanes containing either the undigested or trypsin-digested SR were 
sliced to separate protein bands, background, and lipids that migrate 
with the dye front. Gel slices were dissolved in 30% H202 at 60°C for 
6 h, and radiolabel incorporation was determined by scintillation 
counting. Before slicing the stained gels were photographed, and the 
film was scanned to determine the amount of protein in the bands 
representing the undigested SERCA1 and its tryptic fragments. The 
data represent analysis performed for 4 preparations using SDS-
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PAGE according to Laemmli and for 2 using the Weber-Osborn 
method. 
Controlled proteolysis of SERCA1 was performed using trypsin 
under standard conditions which produce well-characterized frag-
ments A, B, Ai, and A2 [15,16], Briefly, unlabeled or photoaffinity-
labeled membranes were exposed to trypsin at a trypsin/SR protein 
ratio of 0.005 or 0.020 for 10 min at 25°C in the presence of 50 mM 
Tris-maleate, pH 7.4 and 80 mM KC1. The reaction was stopped by 
addition of soybean trypsin inhibitor at 5:1 trypsin inhibitor/trypsin 
ratio. The membranes were solubilized in sample buffer at 50°C for 
30 min before loading on the gel. To differentiate between tryptic 
fragments A and B (and their derivatives) SR was labeled with fluo-
rescein 5'-isothiocyanate (FITC) which binds selectively to Lys-515 
[25,26]. Unreacted label was removed by washing. FITC fluorescence 
in protein bands after SDS-PAGE was observed under a fluorescent 
lamp before the gel was stained for protein. 
Determination of the K\ of halothane was performed with 70 uM 
[14C]halothane in the presence of 0.17-6.8 mM unlabeled halothane. 
SR protein concentration was 0.5 mg/ml in a total volume of 2 ml. 
The samples were exposed for 60 s to 254 nm light, as described 
above. The cuvette contents were vacuum filtered through GF/B fil-
ters, and extensively washed with cold buffer. Retained label on the 
filters was counted by liquid scintillation. Data points represent trip-
licates. 
Ca2+-ATPase activity of unlabeled SR was followed by the colori-
metric determination of P¡ according to Lecocq and Inesi [27]. Activ-
ity was assayed at 25°C in a reaction mixture containing 50 mM Tris-
maleate, pH 7.4, 120 mM KC1, 8 mM MgCl2, 1 mM EGTA, 17 uM 
free Ca2+, 3 mM ATP, and 10 uM ionophore A23187 [1,28]. The 
assay was performed in sealed polypropylene tubes and halothane 
was delivered to the tube from an air-tight Hamilton syringe. 
Protein concentration was determined by the Bio-Rad Protein Mi-
cro-assay based on the Bradford dye-binding procedure using BSA as 
a standard and by UV absorbance (e280 = 1.4X 10
5 M _ 1 cm - 1) [29]. 
3. Results and discussion 
Photoaffinity labeling of SR with [14C]halothane resulted in 
stable label incorporation (not removable by membrane wash-
ing). 
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Fig. 1. Specific binding of [14C]halothane to SR. SR membranes, 
equilibrated with increasing concentrations of unlabeled halothane, 
from 0.17 to 6.8 mM, were photolabeled with 70 uM [14C]halo-
thane. Control binding equals 8.9 ± 0.7 nmol/mg SR protein. The er-
ror bars indicate S.E.M. of triplicates, and are shown when their di-
mensions exceed those of the symbols. Line represents a non-linear 
least-squares fit to a sigmoid function, with the best fit found with 
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Fig. 2. Biphasic effect of halothane on SERCA1 function: activation 
and inhibition of Ca2+-ATPase activity. Error bars shown when 
they exceed the dimensions of symbols. 
labeling with 70 uM [14C]halothane was performed in the 
presence of 0.17-6.8 mM unlabeled halothane (Fig. 1). These 
experiments reveal ~ 80% inhibitable binding with a K\ = 0.6 
mM for halothane. It has been demonstrated previously for 
BSA and the nAChR, that the K\ values generated using cold 
halothane as a competitor for [14C]halothane are close to the 
KQ determined from Scatchard analysis of saturation binding 
isotherms [9,10]. This value coincides with stimulation of the 
Ca2+-ATPase activity of SERCA1 (as shown previously in [1] 
and in more detail in Fig. 2). The biphasic effect explains why 
reports in the literature vary from activatory to inhibitory to 
no effect of halothane depending on the anesthetic concentra-
tion at which they were studied [4,6-8]. The fact that the 
halothane Ki approximates the 750 for stimulation of Ca
2+-
ATPase activity suggests that the two may be related. Inhib-
ition of the enzyme may depend on occupancy of other, lower 
affinity sites in the protein, or possibly may be mediated 
through lipids. 
Under the experimental conditions (60 s UV exposure) total 
incorporation of label was 8.9 ±0.7 nmol per mg protein. In 
calculating the stoichiometry of halothane binding to SER-
CA1 we considered the following facts. Of the total label 
incorporation 47-62%o was recovered in protein, 80-90%> of 
which bound to SERCA1 (Mr = 110000) which comprised 
~ 80%) of the total SR protein. Thus, 3.4-5 nmol of anesthetic 
bind per mg SERCA1; this translates into a 0.34-0.5:1 molar 
anesthetic:enzyme ratio. The value represents an underestima-
tion of unknown proportions since, in contrast to K\ values, it 
depends on the UV 'dose' [10]. UV exposure to complete 
photolysis of [14C]halothane was deliberately not carried out 
in order to avoid cross-linking of protein and subsequent 
difficulty with separation. 
To determine the distribution of [14C]halothane into lipids 
and proteins, and particularly into the SERCA1 protein, we 
subjected the labeled SR to SDS-PAGE. After Coomassie 
Blue staining for protein, the entire lanes were sliced to sep-
arate protein bands, background, and lipids migrating with 
the dye front (see Section 2). Scintillation counting revealed 
47-62% of the label incorporated into protein (38%—53% in 
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Fig. 3. Electrophoretic pattern of control (A) and [14C]halothane-la-
beled (B) SERCA1 in undigested (lane 1) and trypsin-digested (lanes 
2,3) SR vesicles. Trypsin/SR protein ratio was either 0.005 (lane 2) 
or 0.020 (lane 3). Asterisks denote bands (undigested enzyme, frag-
ment B and its derivatives) in which FITC fluorescence was ob-
served before the gel was stained with Coomassie Blue. Most fluo-
rescence (large asterisks) was observed in undigested 110 kDa (lane 
1) and fragment B (lane 2). Electrophoresis was performed on 10-
15% gradient gel according to Laemmli. The Mr values shown are 
for Rainbow molecular weight standards from Amersham. 
the lipids). Thus, 38-56% of the total labeling was recovered 
in SERCA1. A similar distribution of bound [14C]halothane 
between lipids and protein was observed in nAChR [11]. 
To test whether the anesthetic binds preferentially in certain 
domains or indiscriminately all over the protein, we per-
formed controlled tryptic digestion of SERCA1 (Fig. 3). 
Comparison of Fig. 3A vs. B shows that the labeled SR and 
its tryptic digestion patterns are comparable to those of the 
unlabeled SR indicating that UV exposure and [14C]halothane 
binding do not cause any significant changes in the protein 
structure that would affect accessibility to the protease. Upon 
the initial trypsin cleavage at Arg-505 fragments, A and B 
were produced, followed by the appearance of fragments Ax 
and A2 when A was subsequently cleaved at Arg-198. Com-
parison of 14C label content in excised protein bands from 
control and trypsin-digested SR indicates that (1) the total 
amounts of counts (cpm) recovered from the two lanes (un-
digested vs. digested SR) run in parallel were comparable 
within 5-15%, (2) recovery of label from protein and lipid 
fractions was similar, and (3) the level of labeling in the 110 
kDa band diminished to zero upon increase in the trypsin to 
protein ratio with parallel accumulation of tryptic fragments 
of molecular mass lower than 20 kDa. SDS-PAGE according 
to Weber and Osborn allowed for separation of fragments A 
and B (not shown) which in the Laemmli system (that does 
not separate the fragments clearly) were identified by fluores-
cence of FITC attached to Lys-515 in the nucleotide binding 
domain located in fragment B (Fig. 3A). 
Analyses of 14C incorporation (by scintillation counting of 
dissolved gel slices) and protein estimation (from gel scanning) 
of the samples resolved by the two SDS-PAGE systems pro-
duced comparable labeling patterns (labeling to protein ra-
tios). Fig. 3 shows an example of protein resolution in the 
Laemmli system. The 14C label to protein ratio in the tryptic 
fragments (lane 2), as related to the 110 kDa protein band in 
the undigested SR run in parallel (lane 1) was: 0.29 in mostly 
A (the upper band of the two in the area of Mx« 55 kDa 
which shows little FITC fluorescence), 0.17 in B, 0.09 in Ai, 
and 0.37 in A2. Taking into account the molecular mass, the 
above values translate into the following molar ratios of 
[14C]halothane incorporation: 0.43 per 110 kDa, 0.29 per 
fragment A, 0.17 per fragment B, and for fragments Ai and 
A2 (including also analysis of the experiment shown in lane 3) 
0.06-0.086 and 0.16-0.21, respectively. Interestingly, the sum 
of halothane molecules bound in fragment K\ and A2 is very 
close to the stoichiometry obtained for fragment A, and the 
sum of anesthetic molecules in A and B to that for the un-
digested 110 kDa, which is also in agreement with the stoi-
chiometry derived from the binding experiments illustrated in 
Fig. 1. While these numbers need to be treated as only ap-
proximate they give a good indication of binding in various 
parts of the enzyme that are separated by trypsin digestion. 
The distribution of 14C labeling does not seem to correlate to 
either the relative molecular mass or the number of the puta-
tive transmembrane domains in the three fragments (2 trans-
membrane domains in each Ai of Mrs=35000 and A2 of 
A/r = 23 000 and 6 transmembrane domams in fragment B 
of Mr« 55 000). In addition, while the prominent labeling of 
fragment A2 does not exclude halothane binding in the nu-
cleotide binding site it is different from the adenylate kinase 
for which X-ray data analysis shows the anesthetic bound 
only in the internal hydrophobic pocket containing the bind-
ing site for the substrate AMP [30]. The results suggest a 
possibility of preferential binding of volatile anesthetics in 
discrete sites in SERCA1 molecule, which may then produce 
subtle conformational changes that affect enzymatic function, 
and are a first step towards characterization of the sites. 
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